Wirk, B. and Lim, J. 2025. Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma. Journal of Hematology. (Apr. 2025). DOI:https://doi.org/10.14740/jh2046.